Physician

Zachary David Jacobs, MD

According to 2025 Medicare claims, Zachary Jacobs, MD (NPI: 1215033840) practices allergy/immunology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Clay, MO. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS INC (NPI: 1831531466; TIN: 463233706) and primary practice location at 64151-5100. Jacobs is affiliated with the Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Jacobs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 249 traditional Medicare patients, billed 18,671 HCPCS/CPT codes, and received $529,449 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 802 prescription claims across 181 beneficiaries totaling $235,291 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 726 claims. Open Payments data shows 1 records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $767,922 to $529,449. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $236,288 and ending at $235,291. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $4,636 to $17,210.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	193	27,095	$767,922
2016	317	36,451	$994,416
2017	304	43,898	$1,038,072
2018	278	34,552	$876,249
2019	345	46,232	$981,347
2020	290	42,579	$949,770
2021	243	24,797	$633,191
2022	248	24,874	$580,893
2023	234	24,995	$604,340
2024	249	18,671	$529,449

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	630	$236,288
2016	149	736	$259,704
2017	134	647	$621,481
2018	127	648	$1,221,347
2019	147	764	$190,515
2020	134	738	$190,116
2021	135	747	$172,474
2022	146	766	$142,698
2023	165	727	$158,991
2024	181	802	$235,291

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	261	$533,806
2016	N/R	324	$700,727
2017	26	495	$797,807
2018	24	550	$773,031
2019	28	556	$765,184
2020	36	707	$1,070,410
2021	50	934	$1,531,451
2022	57	912	$1,477,587
2023	47	741	$1,330,136
2024	48	726	$1,249,470

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	240	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	69	$54
82784	Gammaglobulin (immune system protein) measurement	68	261	$9
36415	Insertion of needle into vein for collection of blood sample	82	112	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	58	89	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	12	336	$89,901
Nucala	Mepolizumab	12	336	$44,089
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	1,170	$24,552
Breo Ellipta	Fluticasone/Vilanterol	20	600	$7,989
Spiriva Respimat	Tiotropium Bromide	15	450	$7,174

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	11	104	$658,330
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	68	$296,823
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	27	$103,487
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	25	$56,269
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	12	$37,439

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$1,304	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Zachary David Jacobs, MD?

Tedicare shows public-source Medicare data for Zachary David Jacobs, MD (NPI 1215033840), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zachary David Jacobs, MD have ACO affiliation data?

Zachary David Jacobs, MD is shown with ACO affiliation data for Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Zachary David Jacobs, MD?

Zachary David Jacobs, MD is linked to KANSAS CITY PHYSICIAN PARTNERS INC (billing NPI 1831531466) in the available physician profile data.

Does Zachary David Jacobs, MD have Open Payments data?

Zachary David Jacobs, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.